Literature DB >> 33729851

A Novel Secondary Neoplasm Following Allogeneic Hematopoietic Stem Cell Transplant: Mixed Donor-Recipient Primitive Mesenchymal Proliferation of the Liver.

Brian Earl1, Zi Fan Yang1, Harini Rao2, Grace Cheng2,3, Donna Wall1,2,3, Bo-Yee Ngan1,4.   

Abstract

Post-hematopoietic stem cell transplant secondary solid neoplasms are uncommon and usually host-derived. We describe a 6-year-old female who developed a mixed donor-recipient origin mesenchymal stromal tumor-like lesion in the liver following an unrelated hematopoietic stem cell transplant complicated by severe graft-versus-host disease. This lesion arose early post-transplant in association with hepatic graft-versus-host disease. At 12 years post-transplant, the neoplasm has progressively shrunken in size and the patient remains well with no neoplasm-associated sequelae. This report characterizes a novel lesion of mixed origin post-transplant and offers unique insights into the contribution of bone marrow-derived cells to extra-medullary tissues.

Entities:  

Keywords:  bone marrow transplant; graft vs host disease; immunocompromised hosts; late effects; liver; pediatric; stem cell transplantation; tumors

Mesh:

Year:  2021        PMID: 33729851      PMCID: PMC8278562          DOI: 10.1177/10935266211001656

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  22 in total

1.  Hematopoietic origin of glomerular mesangial cells.

Authors:  Masahiro Masuya; Christopher J Drake; Paul A Fleming; Christopher M Reilly; Haiqun Zeng; William D Hill; Angeline Martin-Studdard; David C Hess; Makio Ogawa
Journal:  Blood       Date:  2002-11-14       Impact factor: 22.113

Review 2.  Hematopoietic origin of fibroblasts/myofibroblasts: Its pathophysiologic implications.

Authors:  Makio Ogawa; Amanda C LaRue; Christopher J Drake
Journal:  Blood       Date:  2006-07-13       Impact factor: 22.113

Review 3.  Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update.

Authors:  P Bioulac-Sage; C Balabaud; P Bedossa; J Y Scoazec; L Chiche; A P Dhillon; L Ferrell; V Paradis; T Roskams; V Vilgrain; I R Wanless; J Zucman-Rossi
Journal:  J Hepatol       Date:  2007-01-02       Impact factor: 25.083

Review 4.  Tumour-cell fusion as a source of myeloid traits in cancer.

Authors:  John M Pawelek
Journal:  Lancet Oncol       Date:  2005-12       Impact factor: 41.316

Review 5.  Donor-derived solid malignancies after hematopoietic stem cell transplantation.

Authors:  Yong-xian Hu; Qu Cui; Bin Liang; He Huang
Journal:  Onkologie       Date:  2010-03-19

6.  Endothelial chimerism in chronic sclerotic-type chronic graft-versus-host disease (GVHD) and GVHD-associated angiomatosis.

Authors:  B H Kaffenberger; E Zhang; J R Duncan; S Jaglowski; R B Klisovic; S M Devine; H K Wong; A A Gru
Journal:  Br J Dermatol       Date:  2016-06-10       Impact factor: 9.302

7.  Analysis of tissues following mesenchymal stromal cell therapy in humans indicates limited long-term engraftment and no ectopic tissue formation.

Authors:  L von Bahr; I Batsis; G Moll; M Hägg; A Szakos; B Sundberg; M Uzunel; O Ringden; K Le Blanc
Journal:  Stem Cells       Date:  2012-07       Impact factor: 6.277

8.  Gastric cancer originating from bone marrow-derived cells.

Authors:  Jeanmarie Houghton; Calin Stoicov; Sachiyo Nomura; Arlin B Rogers; Jane Carlson; Hanchen Li; Xun Cai; James G Fox; James R Goldenring; Timothy C Wang
Journal:  Science       Date:  2004-11-26       Impact factor: 47.728

9.  Dynamic of distribution of human bone marrow-derived mesenchymal stem cells after transplantation into adult unconditioned mice.

Authors:  Carolina Allers; Walter D Sierralta; Sonia Neubauer; Francisco Rivera; José J Minguell; Paulette A Conget
Journal:  Transplantation       Date:  2004-08-27       Impact factor: 4.939

10.  Comparative Characterization of Cells from the Various Compartments of the Human Umbilical Cord Shows that the Wharton's Jelly Compartment Provides the Best Source of Clinically Utilizable Mesenchymal Stem Cells.

Authors:  Arjunan Subramanian; Chui-Yee Fong; Arijit Biswas; Ariff Bongso
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.